Antiviral treatment
搜索文档
Cocrystal Pharma to Present at the Noble Capital Markets’ 21st Emerging Growth Equity Conference
Globenewswire· 2025-12-01 21:00
BOTHELL, Wash., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces that James Martin, CFO and co-CEO, will present a Company overview and clinical progress update at NobleCon 21 – Noble Capital Markets 21st Emerging Growth Equity Conference on Wednesday, December 3, 2025 at 10:00 am Eastern time. The conference is being held at the Executive Education Complex of Florida Atlantic University in Boca Raton, Florida. Interested investors and guests o ...
Sunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus Infections
Accessnewswire· 2025-10-09 20:00
公司研发进展 - 公司宣布开发出一系列新型口服活性非共价蛋白酶抑制剂 [1] - 新药在感染SARS冠状病毒的小鼠中显示出剂量依赖性的抗病毒活性 [1] - 研发工作在与亚利桑那大学的持续合作框架下进行 [1] 公司业务领域 - 公司是一家制药公司 提供并研究包括肿瘤学和抗病毒药物在内的多种治疗领域的救命药物 [1]